WILMINGTON, N.C., Nov. 2 Inclinix, Inc. announces today the launch of its new website at www.inclinix.com. The updated site is a result of extensive planning, design and development. Inclinix.com provides visitors with a clear understanding of the Inclinix Performance Enrollment model through intuitive navigation, a clean design, and a concise presentation of the most relevant information in an easy-to-use layout.
Inclinix, Inc. is a contract research organization (CRO) specializing in enrollment solutions for clinical trials in the pharmaceutical, biotechnology and medical device industries. Inclinix has been providing global investigator site selection and patient recruitment, education and retention services since 1999 and has led the industry with a pay-for-performance pricing model.
"We understand that our visitors don't have much time to sort through complicated websites looking for the information they need," explains Christopher Sleat, Chief Marketing Officer at Inclinix. "The new inclinix.com not only showcases the creative design and presentation that Inclinix delivers to our clients, it also enhances the user experience with a clean and well-organized navigation system."
For more information visit www.inclinix.com.
Inclinix, Inc. is a global enrollment contract research organization (CRO) specializing in customized Phase I - IV clinical trial enrollment solutions. Inclinix services deliver productive investigative sites and qualified patients for Sponsors, resulting in successfully completed clinical trials for the pharmaceutical, biotech and medical device industries. Comprehensive enrollment solutions include site recruitment, patient recruitment, clinical and medical marketing communications, patient compliance and education, and the InSite Screener(TM) and InSite Patient Tracker(TM) for comprehensive patient qualification and retention. Since 1999, Inclinix (formerly PharmaTech Solutions, Inc.) has participated in over 400 clinical trials in over 130 indications. Inclinix corporate headquarters is located in Wilmington, North Carolina with additional offices in Annapolis, Maryland, and Gothenburg, Sweden.
SOURCE Inclinix, Inc.